Send Feedback
Print
Mobile
Back
Severe Acute Pain
Opioids are the most potent analgesics and should be used where there is a diagnosis of severe pain. The summary guidelines for intermittent opioid dosing for acute pain are as follows. They are reproduced in card form for attaching to identity card lanyards.
Adult Guidelines for Intermittent Opioids - Oral, Intravenous, Subcutaneous
General considerations
Dose prediction
- Initial dosing: for the opioid naïve patient, begin at lower end of dose range.
- Age: best dose predictor. Lower doses are usually required with increasing age.
- Renal impairment: morphine may be inappropriate (see general considerations). Consider longer dosing interval.
- Weight: dose adjustment may be required at extremes of body weight.
- General physical condition, frailty: less opioid if frail or poor general condition.
- Pre-existing opioid use: opioid tolerance occurs with long term opioids, larger doses often required.
Discharge
- Opioids are not recommended for routine prescription on discharge.
- If prescribed, the patient and patient's GP should be informed.
- Discharge summary should include plan for weaning opioid.
- Recommend 1 week only in decreasing daily doses. Please prescribe a maximum amount to be dispensed.
- If pain requires opioid beyond this time, a GP review is required.
- Prescribed doses should not exceed last inpatient doses.
Dosing Guide for Acute Pain
|
|
|
|
|
Dosing Guide for Acute Pain Intermittent Opioids (oral, intravenous, subcutaneous)
|
Morphine Oral * (1st line)
|
|
Oxycodone Oral * (2nd line)
|
Age
|
Suggested Dose q2h prn
|
|
Age
|
Suggested Dose q2h prn
|
16-39
|
10 - 30 mg
|
|
16-39
|
5 - 15 mg
|
40-59
|
10 - 20 mg
|
|
40-59
|
5 - 10 mg
|
60-69
|
5 - 15 mg
|
|
60-69
|
2.5 - 7.5 mg
|
70-85
|
5 - 10 mg
|
|
70-85
|
2.5 - 5 mg
|
85+
|
2.5 - 5 mg
|
|
85+
|
2.5 mg
|
* Immediate release
Note: The oxycodone oral dose is half that of morphine oral.
|
|
|
|
|
|
Morphine Intravenous
|
|
Fentanyl Intravenous
|
Age
|
Suggested Dose q5 min
|
|
Age
|
Suggested Dose q5 min
|
16-39
|
2 mg
|
|
16-39
|
40 micrograms
|
40-59
|
1.5 mg
|
|
40-59
|
30 micrograms
|
60-80
|
1 mg
|
|
60-80
|
20 micrograms
|
80+
|
0.5 mg
|
|
80+
|
10 micrograms
|
|
|
|
|
|
Morphine Subcutaneous
|
|
Fentanyl Subcutaneous
|
Age
|
Suggested Dose q2h prn
|
|
Age
|
Suggested Dose q2h prn
|
16-39
|
5 - 10 mg
|
|
16-39
|
50 - 100 micrograms
|
40-59
|
4 - 7.5 mg
|
|
40-59
|
40 - 75 micrograms
|
60-69
|
2.5 - 5 mg
|
|
60-69
|
25 - 50 micrograms
|
70-85
|
1.5 - 3 mg
|
|
70-85
|
15 - 30 micrograms
|
85+
|
1 - 2 mg
|
|
85+
|
10 - 20 micrograms
|
Notes
- Morphine remains the gold standard and is generally well tolerated, although nausea can be a problem along with constipation.
- If taking regular morphine or oxycodone e.g. for cancer pain, the q2h prn oral (or subcut) breakthrough dose needs to be 1/6 to 1/10 of the total daily oral (or subcut) dose.
- Fentanyl, a synthetic opioid, can also be used, especially where severe pain is anticipated in certain procedures. Transdermal fentanyl (fentanyl transdermal patch) is not appropriate for the management of acute pain, but can be used for chronic management. Discuss with APMS.
- Tramadol can be used as a second line of management after morphine in acute pain. It causes less constipation and has a quick onset of action. The parenteral dose is the same as the oral dose. May cause confusion in the elderly, and may cause Serotonin Toxicity.
- Pethidine is not recommended. It does not have any specific benefit in smooth muscle spasm. It has a short half-life. Pethidine is almost never used in chronic/persistent pain, as there are more effective and less toxic alternatives such as transdermal fentanyl, oxycodone and methadone. Pethidine toxicity with convulsions can be an issue.
- Local anaesthetic agents can be useful for providing sensory block of specific dermatomes, e.g., femoral nerve block for fractured femur, and abdominal wound catheters.
A wide range of modalities is used to manage severe acute pain. These include:
- Patient controlled analgesia (PCA).
- Regional nerve and wound blocks/catheters.
- Intrathecal morphine.
- Epidural infusions.
Perioperative care has been improved with newer anaesthetic and analgesic techniques, development of minimally invasive surgery, and drugs to reduce surgical stress. Fast-track surgery or enhanced postoperative recovery programmes have been developed by combining these techniques with evidence-based adjustments to the use of nasogastric tubes, drains, and urinary catheters, preoperative bowel preparation, and early initiation of oral feeding and mobilization. This needs 'the right care, delivered to the right patient at the right time, by the right person, in the right way'.
The Acute Pain Management Service (APMS), available on pager 8114 (Christchurch Hospital) or 7015 (Christchurch Women's) or via the on-call Anaesthetist, can advise on the appropriate technique.
Acute episodes of pain also occur in patients receiving opioids for chronic/persistent pain. In these situations, higher doses of breakthrough analgesia may be needed to gain effect compared to opioid-naive patients. During working hours, advice is available from either the APMS or Palliative Care Service
81473 (or page via the operator) - whoever is deemed most appropriate to involve. In-depth prescribing guidelines for oxycodone and transdermal fentanyl are available in the Palliative Care Guidelines.
Doctor's Responsibilities
- Initial assessment of patient:
- Magnitude and cause of pain.
- Existence of factors that might affect the patient's handling of opioids e.g., weight, children, elderly, liver or renal disease, drug dependence.
- Contraindications e.g., airway obstruction, respiratory failure, hypovolaemia, raised intracranial pressure.
- Decide on drug, method of administration, safe dose range and dose interval (see table) and chart according to hospital protocols/algorithms such as the IV Opioid policy for hospital wards.
- Reassess at regular intervals and adjust prescription accordingly.
Nurse's Responsibilities
- Assess opioid dosing levels at regular intervals.
- Administer opioid according to existing hospital protocols and patient's drug chart.
- Decide on appropriate dose within the dose range on the patient's prescription form using patient's response to previous doses as a guideline.
- Monitor and record pain levels, degree of sedation, blood pressure, respiratory rate, and sat.O2 before and at appropriate intervals after the administration of the opioid. See Frequency of Observation during Acute Pain Medication and Pain and Sedation Scores.
- Request an urgent medical review if the pain protocol/prescription is not fully effective.
Management of Complications
Manage appropriately any untoward effects (see Management of Severe Complications and Management of Opioid Side Effects).
Frequency of Observation during Acute Pain Medication
|
|
Frequency of Observation during Acute Pain Medication
|
Route
|
Frequency(1)
|
IM/subcut
|
1 hour after each dose
|
IV
|
Observations at 0 mins then registered nurse stays with patient for 5 mins. Repeat observations at 5 mins, 15 mins, then when clinically indicated due to concerns.
|
IV infusion
|
1 hourly
|
- More frequent observation may be required in some patients. Pulse, respirations, sedation score and pain score are the recommended minimum observations.
|
Pain and Sedation Scores
|
|
|
|
Pain and Sedation Scores
|
Pain Scores
|
Sedation Scores
|
0
|
No pain
|
0
|
Wide awake
|
1
|
Mild discomfort
|
1
|
Easy to rouse (1a = asleep but easy to rouse)
|
2
|
Moderate discomfort
|
2
|
Constantly drowsy, easy to rouse but unable to stay awake (e.g., falls asleep during conversation)
|
3
|
Painful
|
3
|
Severe sedation, somnolent, difficult to rouse
|
4
|
Severe pain
|
|
5
|
Worst imaginable pain
|
|
Management of Severe Complications
|
|
Management of Severe Complications
|
Complication
|
Management
|
Respiratory Depression
|
|
|
- stimulate patient
- support ventilation and airway - bag and mask
- oxygen by mask
- stop opioid administration (1)
- give naloxone (2)
|
|
- stop opioid administration (1)
- give oxygen by mask
|
Excessive Sedation (not rousable by verbal stimuli)
|
- oxygen by mask
- stop opioid administration
- nurse in recovery position
- consider other causes
|
- In palliative care patients, consider delaying and/or reducing the dose of opioid rather than stopping.
- Naloxone 0.2-0.4 mg IV injection repeated every 2-3 minutes until desired effect. May need up to 10 mg (maximum dose). Monitoring essential as the effect of naloxone can wear off before that of the opioid. (The t½ of naloxone is ~1 hour which is shorter than most opioids.)
|
Adjuncts to Opioids for Severe Acute Pain
NSAIDs remain the standard approach, but are relatively contraindicated where there is a bleeding disorder, renal dysfunction, or upper GI dysfunction.
Topic Code: 1569